Purpose of the Procedure
- Identify high-risk HPV genotypes such as 16, 18, 31, and 45
- Assess the risk of developing cervical intraepithelial neoplasia
- Guide clinical decisions for follow-up and management
Identify high-risk HPV strains early with our expanded genotyping test. This precise screening helps in cervical cancer risk stratification, providing essential peace of mind and proactive health management.
Scientific name: Expanded HPV Genotyping Test
A precise molecular test identifying high-risk HPV genotypes like 16, 18, 31, and 45. It stratifies cervical cancer risk, enabling personalized clinical management and early intervention for women.